Leukemia Patient Cancer-Free After T-Cell Therapy

A 23-year-old woman appears to be free of leukemia following T-cell therapy.

Lynsie Conradi of Bellingham, Wash., had been diagnosed with acute lymphoblastic leukemia, a cancer that is generally highly treatable and curable. For a small percentage of patients, however, the disease is refractory to treatment and is fatal. Conradi's leukemia had relapsed twice.

Cancer trial at Seattle Children’s Hospital

She, therefore, entered a cellular immunotherapy Phase 1 cancer trial at Seattle Children’s Hospital. The trial is recruiting patients between 18 and 26 years of age with acute lymphoblastic leukemia that is refractory to treatment and who are believed to have a 20 percent chance of survival.

The trial involves taking a blood sample from the patient, reprogramming the infection-fighting T-cells to seek and destroy leukemia cells according to cell surface antigens, and then returning the blood to the patient's body.

"Results show that Lynsie has had a positive response to the T-cell therapy and, at this time, we do not detect any leukemia cells," said the trial's principal investigator.

Conradi's therapy is not finished, though. Now she must undergo a stem cell transplant, which will function as a sort of consolidation therapy to wipe her body entirely clean of any excess leukemia cells.

For information on the Phase 1 trial, call Seattle Children’s Cancer and Blood Disorders Center at 206-987-2106 or toll-free at 866-987-2000.

Source: Seattle Children's

More Articles

More Articles

This article looks at the Non-Hodgkin's Lymphoma survival rate as well as the Non-Hodgkin's Lymphoma mortality rate ....

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Canine lymphoma is a fairly common cancer in American dogs. The most commonly seen lymphoma in America is a type called Lymphosarcoma, although...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

What causes lymphoma is not well known. DNA mutations may be what causes lymphoma to develop but what triggers these mutations is...

Often the one who makes the first diagnosis of Hodgkin's Lymphoma / Disease is the person affected. There are some...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...